Bio

Dr. Dionysis Papadatos-Pastos is an accomplished thoracic oncologist with over 20 years of experience specialising in lung cancer, mesothelioma, thymoma, and thymic cancer. He leads the lung cancer programme at the CRUK UCL Clinical Trials Centre, driving advancements in thoracic oncology.

After earning his medical degree in 2002, Dr. Papadatos-Pastos completed a PhD in molecular oncology, focusing on prognostic and predictive biomarkers. He received advanced training in medical oncology at renowned UK cancer centres and completed a fellowship at the Royal Marsden’s phase I clinical trials unit. He also holds a diploma in medical oncology from the Institute of Cancer Research at the University of London.

Throughout his career, Dr. Papadatos-Pastos has led pivotal clinical trials for lung cancer and mesothelioma, earning the prestigious ASCO Merit Award in 2010. His research, published in leading medical journals, emphasises personalised treatment plans utilising immunotherapy, targeted therapies, and innovative clinical trials.

Dr. Papadatos-Pastos adopts a multidisciplinary approach, collaborating with experts across specialties to provide holistic, patient-centred care. He is dedicated to supporting patients and families through their treatment journey, combining medical expertise with compassion.

Outside work, he mentors aspiring doctors, enjoys swimming, and values time with his family. This reflects his commitment to excellence in patient care and education.